| Effects of metabolic modulation by trimetazidine on left ventricular function and phosphocreatine/adenosine triphosphate ratio in patients with heart failure G Fragasso, G Perseghin, F De Cobelli, A Esposito, A Palloshi, ... European heart journal 27 (8), 942-948, 2006 | 412 | 2006 |
| A randomized clinical trial of trimetazidine, a partial free fatty acid oxidation inhibitor, in patients with heart failure G Fragasso, A Palloshi, P Puccetti, C Silipigni, A Rossodivita, M Pala, ... Journal of the American College of Cardiology 48 (5), 992-998, 2006 | 399 | 2006 |
| Short-and long-term beneficial effects of trimetazidine in patients with diabetes and ischemic cardiomyopathy G Fragasso, PM Piatti, L Monti, A Palloshi, E Setola, P Puccetti, G Calori, ... American heart journal 146 (5), 854, 2003 | 370 | 2003 |
| Association of insulin resistance, hyperleptinemia, and impaired nitric oxide release with in-stent restenosis in patients undergoing coronary stenting PM Piatti, C Di Mario, LD Monti, G Fragasso, F Sgura, A Caumo, E Setola, ... Circulation 108 (17), 2074-2081, 2003 | 284 | 2003 |
| Effects of trimetazidine on ischemic left ventricular dysfunction in patients with coronary artery disease C Lu, P Dabrowski, G Fragasso, SL Chierchia American Journal of Cardiology 82 (7), 898-901, 1998 | 279 | 1998 |
| Anthracycline-induced cardiotoxicity: A multicenter randomised trial comparing two strategies for guiding prevention with enalapril: The International CardioOncology Society … D Cardinale, F Ciceri, R Latini, MG Franzosi, MT Sandri, M Civelli, ... European journal of cancer 94, 126-137, 2018 | 229 | 2018 |
| Effect of oral L-arginine on blood pressure and symptoms and endothelial function in patients with systemic hypertension, positive exercise tests, and normal coronary arteries A Palloshi, G Fragasso, PM Piatti, LD Monti, E Setola, G Valsecchi, ... The American journal of cardiology 93 (7), 933-935, 2004 | 205 | 2004 |
| Insulin resistance and endothelial function are improved after folate and vitamin B12 therapy in patients with metabolic syndrome: relationship between homocysteine levels and … E Setola, LD Monti, E Galluccio, A Palloshi, G Fragasso, R Paroni, ... European journal of endocrinology 151 (4), 483-489, 2004 | 204 | 2004 |
| Acute Intravenous l-Arginine Infusion Decreases Endothelin-1 Levels and Improves Endothelial Function in Patients With Angina Pectoris and Normal Coronary … PM Piatti, G Fragasso, LD Monti, E Setola, P Lucotti, I Fermo, R Paroni, ... Circulation 107 (3), 429-436, 2003 | 184 | 2003 |
| Effect of partial fatty acid oxidation inhibition with trimetazidine on mortality and morbidity in heart failure: results from an international multicentre retrospective cohort … G Fragasso, G Rosano, SH Baek, H Sisakian, P Di Napoli, L Alberti, ... International journal of cardiology 163 (3), 320-325, 2013 | 167 | 2013 |
| Dissociation of platelet activation and spontaneous myocardial ischemia in unstable angina M Vejar, G Fragasso, D Hackett, DP Lipkin, A Maseri, GVR Born, ... Thrombosis and haemostasis 63 (02), 163-168, 1990 | 165 | 1990 |
| Comparison of stress/rest myocardial perfusion tomography, dipyridamole and dobutamine stress echocardiography for the detection of coronary disease in hypertensive patients … G Fragasso, C Lu, P Dabrowski, P Pagnotta, I Sheiban, SL Chierchia Journal of the American College of Cardiology 34 (2), 441-447, 1999 | 163 | 1999 |
| Metabolic and endothelial effects of trimetazidine on forearm skeletal muscle in patients with type 2 diabetes and ischemic cardiomyopathy LD Monti, E Setola, G Fragasso, RP Camisasca, P Lucotti, E Galluccio, ... American Journal of Physiology-Endocrinology and Metabolism 290 (1), E54-E59, 2006 | 137 | 2006 |
| Time course and determinants of left ventricular function recovery after primary angioplasty in patients with acute myocardial infarction I Sheiban, G Fragasso, GMC Rosano, A Dharmadhikari, V Tzifos, ... Journal of the American College of Cardiology 38 (2), 464-471, 2001 | 136 | 2001 |
| Relationship between endothelin-1 concentration and metabolic alterations typical of the insulin resistance syndrome PM Piatti, LD Monti, L Galli, G Fragasso, G Valsecchi, M Conti, F Gernone, ... Metabolism 49 (6), 748-752, 2000 | 134 | 2000 |
| Sodium–glucose co‐transporter 2 inhibitors in heart failure: beyond glycaemic control. A position paper of the Heart Failure Association of the European Society of Cardiology PM Seferović, G Fragasso, M Petrie, W Mullens, R Ferrari, T Thum, ... European journal of heart failure 22 (9), 1495-1503, 2020 | 128 | 2020 |
| Specificity and sensitivity of exercise-induced ST segment elevation for detection of residual viability: comparison with fluorodeoxyglucose and positron emission tomography A Margonato, SL Chierchia, RG Xuereb, M Xuereb, G Fragasso, ... Journal of the American College of Cardiology 25 (5), 1032-1038, 1995 | 118 | 1995 |
| Rationale and benefits of trimetazidine by acting on cardiac metabolism in heart failure YM Lopatin, GMC Rosano, G Fragasso, GD Lopaschuk, PM Seferovic, ... International journal of cardiology 203, 909-915, 2016 | 112 | 2016 |
| Coronary slow-flow causing transient myocardial hypoperfusion in patients with cardiac syndrome X: long-term clinical and functional prognosis G Fragasso, SL Chierchia, F Arioli, O Carandente, S Gerosa, M Carlino, ... International journal of cardiology 137 (2), 137-144, 2009 | 111 | 2009 |
| Tumor necrosis factor α as a master regulator of inflammation in Erdheim-Chester disease: rationale for the treatment of patients with infliximab L Dagna, A Corti, S Langheim, B Guglielmi, F De Cobelli, C Doglioni, ... Journal of Clinical Oncology 30 (28), e286-e290, 2012 | 110 | 2012 |
